NTRA - Natera Inc8:00:00 PM 6/14/2024
-0.59 (-0.53%)
Natera is a genetic testing company that operates a CLIA-certified laboratory in San Carlos, California. The company specializes in analyzing microscopic quantities of DNA for reproductive health indications to provide preconception and prenatal genetic testing services to OBGYN physicians and in vitro fertilization centers. In early 2013, the company launched Panorama, a non-invasive prenatal test for pregnant women that screens for the most common chromosomal anomalies in a fetus as early as nine weeks of gestation. Other services include tests for preimplantation genetic diagnosis and miscarriage testing to determine the cause of the loss of the pregnancy. A non-invasive paternity test based on Natera’s technology, was brought to market in August 2011 through a partnership with DNA Diagnostics Center , which holds a license to the technology in the United States.
Quarterly financials
(USD)Dec 2022Q/Q
Operating Income-141.8MM+19%
Operating Expenses359MM-
Net Income-142.6MM+17%
Interest Expense2.8MM+18%
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 


Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news